These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 1472042)
1. NG-hydroxy-L-arginine and hydroxyguanidine potentiate the biological activity of endothelium-derived relaxing factor released from the rabbit aorta. Zembowicz A; Chłopicki S; Radziszewski W; Vane JR; Gryglewski RJ Biochem Biophys Res Commun; 1992 Dec; 189(2):711-6. PubMed ID: 1472042 [TBL] [Abstract][Full Text] [Related]
2. Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor. Zembowicz A; Swierkosz TA; Southan GJ; Hecker M; Vane JR Br J Pharmacol; 1992 Dec; 107(4):1001-7. PubMed ID: 1281716 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of the endothelium-dependent relaxation induced by NG-hydroxy-L-arginine. Zembowicz A; Swierkosz TA; Southan GJ; Hecker M; Gryglewski RJ; Vane JR J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S57-9. PubMed ID: 1282987 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide and another potent vasodilator are formed from NG-hydroxy-L-arginine by cultured endothelial cells. Zembowicz A; Hecker M; Macarthur H; Sessa WC; Vane JR Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11172-6. PubMed ID: 1662386 [TBL] [Abstract][Full Text] [Related]
5. Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta. Zembowicz A; Hatchett RJ; Jakubowski AM; Gryglewski RJ Br J Pharmacol; 1993 Sep; 110(1):151-8. PubMed ID: 7693274 [TBL] [Abstract][Full Text] [Related]
6. L-glutamine inhibits the release of endothelium-derived relaxing factor from the rabbit aorta. Swierkosz TA; Mitchell JA; Sessa WC; Hecker M; Vane JR Biochem Biophys Res Commun; 1990 Oct; 172(1):143-8. PubMed ID: 2222463 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the stable L-arginine-derived relaxing factor released from cytokine-stimulated vascular smooth muscle cells as an NG-hydroxyl-L-arginine-nitric oxide adduct. Hecker M; Boese M; Schini-Kerth VB; Mülsch A; Busse R Proc Natl Acad Sci U S A; 1995 May; 92(10):4671-5. PubMed ID: 7753862 [TBL] [Abstract][Full Text] [Related]
8. Endothelium-dependent, nitric oxide-mediated inhibition of angiotensin II-induced contractions in rabbit aorta. Zhang J; Van Meel JC; Pfaffendorf M; Zhang J; Van Zwieten PA Eur J Pharmacol; 1994 Sep; 262(3):247-53. PubMed ID: 7813589 [TBL] [Abstract][Full Text] [Related]
9. Comparison of effects of chronic and acute administration of NG-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses. Bryant CE; Allcock GH; Warner TD Br J Pharmacol; 1995 Apr; 114(8):1673-9. PubMed ID: 7541283 [TBL] [Abstract][Full Text] [Related]
10. L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Moore PK; al-Swayeh OA; Chong NW; Evans RA; Gibson A Br J Pharmacol; 1990 Feb; 99(2):408-12. PubMed ID: 2328404 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the release of endothelium-derived relaxing factor in vitro and in vivo by dipeptides containing NG-nitro-L-arginine. Thiemermann C; Mustafa M; Mester PA; Mitchell JA; Hecker M; Vane JR Br J Pharmacol; 1991 Sep; 104(1):31-8. PubMed ID: 1786515 [TBL] [Abstract][Full Text] [Related]
12. Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta. Adeagbo AS; Triggle CR Br J Pharmacol; 1993 Jun; 109(2):495-501. PubMed ID: 7689395 [TBL] [Abstract][Full Text] [Related]
13. Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine. Hecker M; Mitchell JA; Harris HJ; Katsura M; Thiemermann C; Vane JR Biochem Biophys Res Commun; 1990 Mar; 167(3):1037-43. PubMed ID: 2322257 [TBL] [Abstract][Full Text] [Related]
16. Differential effects of L-arginine on the inhibition by NG-nitro-L-arginine methyl ester of basal and agonist-stimulated EDRF activity. Randall MD; Griffith TM Br J Pharmacol; 1991 Nov; 104(3):743-9. PubMed ID: 1797335 [TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine. Frew JD; Paisley K; Martin W Br J Pharmacol; 1993 Nov; 110(3):1003-8. PubMed ID: 7507774 [TBL] [Abstract][Full Text] [Related]
18. Effects of metabolic inhibitors on endothelium-dependent and endothelium-independent vasodilatation of rat and rabbit aorta. Weir CJ; Gibson IF; Martin W Br J Pharmacol; 1991 Jan; 102(1):162-6. PubMed ID: 1646055 [TBL] [Abstract][Full Text] [Related]
19. Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-L-arginine and other compounds bearing a C=NOH function in the rat aorta. Vetrovsky P; Boucher JL; Schott C; Beranova P; Chalupsky K; Callizot N; Muller B; Entlicher G; Mansuy D; Stoclet JC J Pharmacol Exp Ther; 2002 Nov; 303(2):823-30. PubMed ID: 12388669 [TBL] [Abstract][Full Text] [Related]
20. Central role of heterocellular gap junctional communication in endothelium-dependent relaxations of rabbit arteries. Chaytor AT; Evans WH; Griffith TM J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):561-73. PubMed ID: 9508817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]